• Covid-19 and Cancer intelligence hub, hosted by ecancer: Rapid reports are critical for getting data in the public domain in these unprecedented times. The intelligence hub serves as a single point of access to current literature, current impact case studies and emerging reports. We encourage you to contribute.

  • Group members are engaged in wide variety of research projects investigating the impact of the COVID-19 crisis on Cancer:

  • While health care providers (HCP) in oncology have traditionally accepted the potential stressors related to caring for patients with malignant disease, there is now an addition of pandemic-related concerns. These include the potential for rationing treatments owing to lack of resources (e.g.
    reduced operating room time, drug shortages, staff shortages) or balancing the risks of COVID-19 infection against the benefits of cancer therapies that might compromise patient immunity or cause illness due to exposure to the hospital environment. The taskforce wishes to quantify and describe these stressors in HCP during the pandemic using an initial cross-sectional approach, and to describe changes over time using longitudinal assessments.

  • The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, particularly those in low- and middle-income countries, as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis. See more for the details of the three areas of work we are prioritizing.

  • IARC is leading a survey to population-based cancer registries worldwide through the International Association of Cancer Registries (IACR), the professional society of registries for which IARC provides the Secretariat. The aim of the survey is to assess the short-term and longer-term impacts of the pandemic on registry operations and subsequent data dissemination in different settings.

    Many thanks to the 132 registries that have contributed - findings to be shared soon!

  • A series of webinars from the taskforce members covering the latest developments in covid and cancer


The coronavirus (COVID-19) pandemic has created massive downward pressure on social, economic and health systems across the world. Cancer patients in all countries and settings have been directly and indirectly impacted.

The Covid-19 and Cancer Taskforce is a globally representative group of cancer leaders spanning the disciplines of cancer across the care continuum from prevention, early detection, treatment and palliative, to representatives of cancer centre networks and advocacy groups.

We are gravely concerned that decisions made under the duress of the pandemic will have momentous consequences for cancer mortality for years to come. National measures are meaning access and availability of timely, affordable and equitable care is under grave threat.

We wish to work with and draw on the expertise of the global cancer community, alongside those of infectious disease and other non-communicable disease, to ensure that data is captured and research conducted to a high quality to:

  • Assess the immediate impacts on cancer patients, services, and healthcare workers as well as treatment decision making and patient/doctor interactions;
  • Address risks for longer term impacts on cancer outcomes, inequalities, research and affordability;
  • Develop an integrated approach to build resilient cancer services with readiness to respond to new pandemics, especially in low- and middle-income countries whose; cancer services are especially vulnerable in the face of this unprecedented public health challenge.